Real-World safety and effectiveness of evolocumab in primary hypercholesterolemia and mixed dyslipidemia in Saudi Arabia

• Автори: Abdulaali R. Almutairi (Автор), Walaa A. Alshahrani (Автор), Ghaida K. Alhathlol (Автор), Fatimah Alsheikh (Автор), Abdulaziz Alakeel (Автор), Majed S. Al Yami (Автор), Mohammad Fouda (Автор), Omar A. Almohammed (Автор), Meshal S. Alhamed (Автор), Awatif Hafiz (Автор), Hussam Kutbi (Автор), Alaa Bagalagel (Автор), Aisha Alharbi (Автор), Mashael Alaboud (Автор), Sarah Aljohani (Автор), Waddah Ashram (Автор)
• Формат: Книга
• Опубліковано: Elsevier, 2024-12-01T00:00:00Z.
• Предмети: article
• Онлайн доступ: Connect to this object online.

Introduction: Evolocumab's short-term efficacy and safety were proven in phase-3 clinical trial, but its long-term safety and effectiveness in the Saudi population are yet to be studied. The aim of this study was to assess the long-term safety and effectiveness of evolocumab in Saudi patients w...